49 results
F-1/A
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
including the total number of complaints received during the period.
It is Company policy that any employee or director who violates this Code … will be subject to appropriate discipline, which may include, for an employee, termination of employment for cause or, for a director, a request
20-F
2021 FY
EX-4.11
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
, and there is no set guideline as
to how much vacation each employee will be permitted to take. Supervisors will approve paid vacation requests based … of the employee. Since vacation is not allotted or accrued, “unused” vacation time will not be carried over from one year to the next nor paid out upon
20-F
2021 FY
EX-4.10
CNTB
Connect Biopharma Holdings Ltd
31 Mar 22
Annual report (foreign)
4:33pm
employees do not accrue vacation, and there is no set guideline as to how much vacation each employee will be permitted to take. Supervisors will approve … and efficiency of the employee. Since vacation is not allotted or accrued, “unused” vacation time will not be carried over from one year to the next
F-1/A
EX-10.4
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
Exhibit 10.4
CONNECT BIOPHARMA HOLDINGS LIMITED
2021 EMPLOYEE SHARE PURCHASE PLAN
ARTICLE I.
PURPOSE
The purpose of this Plan is to assist … components: (i) the Section 423 Component and (ii) the Non-Section 423 Component. The Section 423 Component is intended to qualify as an “employee stock
F-1
EX-10.14
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
are a UK-based employee and $14,583.00 semi-monthly while you are a US-based employee.
After receipt of an O-1 visa allowing you to relocate to and work … not accrue vacation, and there is no set guideline as to how much vacation each employee will be permitted to take. Supervisors will approve paid vacation
F-1/A
EX-10.2
kc5r78h5rw8 1hi1577
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.13
ndk60tnw
26 Feb 21
Registration statement (foreign)
4:56pm
S-8
5w43y2f
1 Jul 22
Registration of securities for employees
5:12pm
F-1
EX-10.11
pfq86
26 Feb 21
Registration statement (foreign)
4:56pm
20-F
EX-4.5
8275hyv3sseuzg
31 Mar 22
Annual report (foreign)
4:33pm
F-1/A
EX-10.3
dh7nerplbr09
17 Mar 21
Registration statement (foreign) (amended)
6:38am
S-8
8q58bol40ufyl5e4dyg9
19 Mar 21
Registration of securities for employees
5:13pm
DRS
EX-10.1
fz0n9b
17 Dec 20
Draft registration statement
12:00am
F-1
EX-10.1
j93lwla0va6dybynw
26 Feb 21
Registration statement (foreign)
4:56pm
F-1/A
EX-10.3
d7qe4kb8 ef7x
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.12
whjifi29f4bbc7et1 vb
26 Feb 21
Registration statement (foreign)
4:56pm
F-1/A
EX-1.1
9uga1nvygyoid
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.15
2b7 gxe1p6ek0n16qr9
26 Feb 21
Registration statement (foreign)
4:56pm
6-K
EX-99.1
d6k33
31 Aug 21
Index to the Unaudited Interim Condensed Consolidated Financial Statements
4:16pm